Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond Endoscopy: A Narrative Review of the Emerging Role of Gastroenterologists in Obesity Medicine, GLP-1 (Glucagon-Like Peptide-1) Therapy, and Metabolic Care.

Cureus·2026
Same author

Long-Term Endoscopic Management of Recurrent High-Grade Dysplasia and Intramucosal Carcinoma in an Inoperable Barrett Patient.

ACG case reports journal·2026
Same author

National Mortality Patterns of Cancer Cachexia in Gastrointestinal Malignancies in the United States: A Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) Analysis (2018-2023).

Cureus·2026
Same author

Impact of the COVID-19 Pandemic on Splanchnic Thrombosis Mortality: A United States National Analysis (2018-2023).

Cureus·2026
Same author

Bayesian Topology Inference of Regulatory Networks under Partial Observability.

Results in control and optimization·2026
Same author

Exploring the Relationship Between Supplement Usage and Quality of Life Among Cancer Patients in Jordan: A Cross-Sectional Study.

Nutrition and cancer·2025

Related Experiment Videos

Predicting Inflammatory Bowel Disease Flares Using Artificial Intelligence and Remote Monitoring: Toward Proactive

Mohammad Alali1, Mouhammad Alyounes2, Mohammad Alkhaleel Alomar2

  • 1Internal Medicine, Henry Ford Hospital, Macomb, USA.

Cureus
|June 1, 2026
PubMed
Summary

Artificial intelligence (AI) and remote monitoring can predict inflammatory bowel disease (IBD) flares. This proactive approach aims to improve patient outcomes by enabling early intervention for Crohn's disease and ulcerative colitis.

Keywords:
artificial intelligenceflare predictioninflammatory bowel diseasemachine learningtelemedicine

Related Experiment Videos

Area of Science:

  • Gastroenterology
  • Biomedical Informatics
  • Digital Health

Background:

  • Inflammatory bowel disease (IBD) management is reactive, often missing early signs of flares.
  • Current treatments struggle to anticipate unpredictable disease exacerbations, impacting patient quality of life.
  • Existing strategies rely on symptoms and biomarkers that indicate established inflammation.

Purpose of the Study:

  • To review artificial intelligence (AI) predictive modeling for IBD flares.
  • To evaluate remote monitoring tools for real-time patient data collection.
  • To explore integrating AI and remote monitoring for proactive IBD management.

Main Methods:

  • Narrative review of current evidence on AI in IBD.
  • Analysis of machine learning models using clinical, biochemical, and behavioral data.
  • Assessment of telemedicine and digital health tools for patient-generated data.

Main Results:

  • AI models show promise in identifying patterns predictive of IBD flares.
  • Remote monitoring facilitates continuous data collection for real-time disease tracking.
  • Integration of AI and remote monitoring offers a framework for early flare detection.

Conclusions:

  • AI and remote monitoring represent a paradigm shift towards proactive IBD management.
  • Early identification of flares through predictive modeling can enable timely intervention.
  • Further research is needed to address validation, generalizability, and clinical implementation challenges.